HearingAssist Eaze vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

HearingAssist Eaze
The HearingAssist Eaze is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.4/5 in our lab testing. At $399, it sits in the most affordable price tier of the OTC market, though it ranks #43 of 65 devices in its category. In our standardized testing, the Eaze demonstrates excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling during typical daily activities. However, the device shows limitations in other areas: speech clarity scores are mixed at 2.6/5 in quiet and low at 1.3/5 in noisy environments, both falling slightly below category averages. The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average. Buyers who prioritize phone streaming for music or media should consider alternatives. Own-voice comfort is also mixed at 2.2/5, approximately 0.31 points below average for OTC devices. At this price point, shoppers have several higher-scoring alternatives to consider, including the Elehear Beyond and Apple AirPods Pro 2, which offer stronger overall performance. The HearingAssist Eaze may suit budget-conscious buyers who prioritize feedback stability over streaming capabilities and can accept modest speech performance in challenging listening situations.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit